Table III.

Cox proportional hazard model of effect on thromboembolic events (TEEs) of treatment type and covariates.

Variable	HR ( 95% CI)
Immunotherapy alone	0·918 (0·788–1·07)
Age	0·994 (0·990–0·999)
CCI score	1·02 (1·01–1·03)
Smoking status	0993 (0·927–1·06)
Edoxaban	6·84 (0·424–110)
LMW heparin	177 (16·0–1967)
Aspirin	0·992 ( 0·915–1·07)
Prior myocardial infarction	1·29 (1·06–1·56)
Metastases	1·21 (1·10–1·34)
Pulmonary disease	0·978 (0·899–1·06)
Congestive heart failure	1·08 (0·999–1·17)
Liver disease	1·03 (0·945–1·12)
Diabetes	0·906 (0·839–0·978)
Vascular disease	1·41 (1·31–1·52)

CCI, Charlson Comorbidity Index; CI, confidence interval; HR, hazard ratio; LMW, low molecular weight.